FARAH AFZAL
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta (NCT04945811) | FARAH AFZAL | 2020-04-01 |
Track FARAH AFZAL automatically
Every clearance here is in the API, with alerts when new ones post.